A股異動丨晶豐明源(688368.SH)大漲10%創歷史新高 績後獲券商唱好
格隆匯4月16日丨晶豐明源(688368.SH)午後拉昇至10%,高見275元創歷史新高價,10個交易日漲幅超40%,總市值達41.7億元。晶豐明源日前發佈2020年報,公司全年實現營收11.03億元,同比增長26.24%;歸母淨利0.69億元,同比下降25.43%。信達證券點評稱,去年公司經歷了“先抑後揚”。Q4營收再創歷史新高,盈利能力持續提升。此外,伴隨着快充家電等高毛利業務起量,公司可靈活調配產能,更加增厚業績彈性。值得注意的是,2021年公司還計劃對計算機和通信領域的電源管理芯片進行技術儲備和預研工作。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.